Quest Diagnostics

Quest Diagnostics Gross Margin

The Gross Margin of Quest Diagnostics (DGX) as of Nov 19, 2026 is 31.93 %. In the previous year, Gross Margin was 32.86 % — a change of -2.85% (lower).

Gross Margin

31.93 %

YoY

-2.85%

Last updated:

Gross Margin of Quest Diagnostics is 2025 31.93 % . Gross Margin of Quest Diagnostics was 2024 32.86 % . It decreases by -2.85% lower compared to the previous year.

For Quest Diagnostics, the gross margin of 31.9% is down versus 39.0% a few years ago.

The Quest Diagnostics Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
34.59 USD
Jan 1, 2019
34.80 USD
Jan 1, 2020
38.50 USD
Jan 1, 2021
39.02 USD
Jan 1, 2022
34.74 USD
Jan 1, 2023
33.00 USD
Jan 1, 2024
32.86 USD
Jan 1, 2025
31.93 USD
The Quest Diagnostics Gross Margin history
YEARGross MarginYoY
31.93 %-2.85%
32.86 %-0.42%
33.00 %-5.00%
34.74 %-10.97%
39.02 %+1.35%
38.50 %+10.61%
34.80 %+0.62%
34.59 %-10.82%
38.79 %+0.54%
38.58 %+1.92%
37.85 %+0.57%
37.63 %+9,436.32%
0.39 %-3.46%
0.41 %-1.45%
0.41 %+0.16%
0.41 %-1.48%
0.42 %+1.80%
0.41 %+1.22%
0.41 %-0.60%
0.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Diagnostics Stock analysis

What does Quest Diagnostics do? Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quest Diagnostics stock

Gross Margin of Quest Diagnostics is 31.93 % in 2025.

Gross Margin of Quest Diagnostics changed from 32.86 % to 31.93 %, representing a -2.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Quest Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Quest Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Quest Diagnostics

All Key Metrics — Quest Diagnostics